The World Health Organization (WHO) guidelines for the treatment of cancer pain recommend nonopioid analgesics as first-line therapy, so-called "weak" analgesics combined with nonopioid analgesics as second-line therapy, and so-called "strong" opioids (with nonopioid analgesics) only as third-line therapy. However, these guidelines can be questioned with regard to the extent of efficacy as well as the rationale for not using strong opioids as first-line treatment, especially in terminal cancer patients. The purpose of this randomized study was to prospectively compare the efficacy and tolerability of strong opioids as first-line agents with the recommendations of the WHO in terminal cancer patients. One hundred patients with mild-moderate pain were randomized to treatment according to WHO guidelines or to treatment with strong opioids. Evaluated outcomes included pain intensity, need for change in therapy, quality of life, Karnofsky Performance Status, general condition of the patient, and adverse events. No between-treatment differences were observed for changes in quality of life or performance status, but patients started on strong opioids had significantly better pain relief than patients treated according to WHO guidelines (P=0.041). Additionally, patients started on strong opioids required significantly fewer changes in therapy, had greater reduction in pain when a change was initiated, and reported greater satisfaction with treatment than the comparator group (P=0.041). Strong opioids were safe and well-tolerated, with no development of tolerance or serious adverse events. These data suggest the utility of strong opioids for first-line treatment of pain in patients with terminal cancer. © 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Use of strong opioids in advanced cancer pain: A randomized trial / Franco, Marinangeli; Alessandra, Ciccozzi; Marco, Leonardis; Luca, Aloisio; Anna, Mazzei; Antonella, Paladini; Giampiero, Porzio; Marchetti, Paolo; Giustino, Varrassi. - In: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. - ISSN 0885-3924. - 27:5(2004), pp. 409-416. [10.1016/j.jpainsymman.2003.10.006]

Use of strong opioids in advanced cancer pain: A randomized trial

MARCHETTI, PAOLO;
2004

Abstract

The World Health Organization (WHO) guidelines for the treatment of cancer pain recommend nonopioid analgesics as first-line therapy, so-called "weak" analgesics combined with nonopioid analgesics as second-line therapy, and so-called "strong" opioids (with nonopioid analgesics) only as third-line therapy. However, these guidelines can be questioned with regard to the extent of efficacy as well as the rationale for not using strong opioids as first-line treatment, especially in terminal cancer patients. The purpose of this randomized study was to prospectively compare the efficacy and tolerability of strong opioids as first-line agents with the recommendations of the WHO in terminal cancer patients. One hundred patients with mild-moderate pain were randomized to treatment according to WHO guidelines or to treatment with strong opioids. Evaluated outcomes included pain intensity, need for change in therapy, quality of life, Karnofsky Performance Status, general condition of the patient, and adverse events. No between-treatment differences were observed for changes in quality of life or performance status, but patients started on strong opioids had significantly better pain relief than patients treated according to WHO guidelines (P=0.041). Additionally, patients started on strong opioids required significantly fewer changes in therapy, had greater reduction in pain when a change was initiated, and reported greater satisfaction with treatment than the comparator group (P=0.041). Strong opioids were safe and well-tolerated, with no development of tolerance or serious adverse events. These data suggest the utility of strong opioids for first-line treatment of pain in patients with terminal cancer. © 2004 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
2004
oncologic pain; opioids; who guidelines
01 Pubblicazione su rivista::01a Articolo in rivista
Use of strong opioids in advanced cancer pain: A randomized trial / Franco, Marinangeli; Alessandra, Ciccozzi; Marco, Leonardis; Luca, Aloisio; Anna, Mazzei; Antonella, Paladini; Giampiero, Porzio; Marchetti, Paolo; Giustino, Varrassi. - In: JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. - ISSN 0885-3924. - 27:5(2004), pp. 409-416. [10.1016/j.jpainsymman.2003.10.006]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/16320
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 165
  • ???jsp.display-item.citation.isi??? 122
social impact